ATE15813T1 - Unloesliches vernetztes zytotoxisches oxidaseperoxidase-system. - Google Patents

Unloesliches vernetztes zytotoxisches oxidaseperoxidase-system.

Info

Publication number
ATE15813T1
ATE15813T1 AT82301451T AT82301451T ATE15813T1 AT E15813 T1 ATE15813 T1 AT E15813T1 AT 82301451 T AT82301451 T AT 82301451T AT 82301451 T AT82301451 T AT 82301451T AT E15813 T1 ATE15813 T1 AT E15813T1
Authority
AT
Austria
Prior art keywords
insoluble cross
peroxidase system
oxidase peroxidase
linked oxidase
linked
Prior art date
Application number
AT82301451T
Other languages
German (de)
English (en)
Inventor
Jonathan L Kiel
Original Assignee
Jonathan L Kiel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jonathan L Kiel filed Critical Jonathan L Kiel
Application granted granted Critical
Publication of ATE15813T1 publication Critical patent/ATE15813T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • A61K38/385Serum albumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/443Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/18Multi-enzyme systems
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004Glucose oxidase (1.1.3.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y111/00Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01Peroxidases (1.11.1)
    • C12Y111/01007Peroxidase (1.11.1.7), i.e. horseradish-peroxidase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT82301451T 1981-04-07 1982-03-19 Unloesliches vernetztes zytotoxisches oxidaseperoxidase-system. ATE15813T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/251,694 US4486408A (en) 1981-04-07 1981-04-07 Insoluble crosslinked cytotoxic oxidase-peroxidase system
EP82301451A EP0062434B1 (en) 1981-04-07 1982-03-19 Insoluble crosslinked cytotoxic oxidase-peroxidase system

Publications (1)

Publication Number Publication Date
ATE15813T1 true ATE15813T1 (de) 1985-10-15

Family

ID=22953019

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82301451T ATE15813T1 (de) 1981-04-07 1982-03-19 Unloesliches vernetztes zytotoxisches oxidaseperoxidase-system.

Country Status (13)

Country Link
US (1) US4486408A (en:Method)
EP (1) EP0062434B1 (en:Method)
JP (1) JPS57177694A (en:Method)
AR (1) AR229260A1 (en:Method)
AT (1) ATE15813T1 (en:Method)
AU (1) AU556620B2 (en:Method)
CA (1) CA1187791A (en:Method)
DE (1) DE3266476D1 (en:Method)
DK (1) DK155082A (en:Method)
IL (1) IL65382A (en:Method)
IN (1) IN156471B (en:Method)
NO (1) NO158004C (en:Method)
ZA (1) ZA821924B (en:Method)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0236610A1 (en) * 1986-03-13 1987-09-16 Laclede Professional Products, Inc. Enzymatic bandages and pads
US4576817A (en) * 1984-06-07 1986-03-18 Laclede Professional Products, Inc. Enzymatic bandages and pads
SE8500341L (sv) * 1985-01-24 1986-07-25 Pharmacia Ab Desinfektionssats samt sett for desinfektion
US4974929A (en) * 1987-09-22 1990-12-04 Baxter International, Inc. Fiber optical probe connector for physiologic measurement devices
AU4402589A (en) * 1988-09-28 1990-04-18 Ideon Corporation Combination enzyme immunotherapeutics
FR2646777B1 (fr) * 1989-05-12 1993-09-03 Bio Serae Lab Procede de preparation d'un produit particulaire antimicrobien, produit antimicrobien obtenu et applications
US5486360A (en) * 1993-04-22 1996-01-23 St. Joseph Health Centre Method of treating tumour cells using catalase
CA2150029A1 (en) * 1993-09-22 1995-03-30 Spencer H. Lin Immobilization of chemically cross-linked proteins on solid supports
US7192766B2 (en) * 2001-10-23 2007-03-20 Medtronic Minimed, Inc. Sensor containing molded solidified protein
WO2013006762A2 (en) * 2011-07-06 2013-01-10 The Regents Of The University Of California Multiple-enzyme nanocomplexes
KR20250004257A (ko) * 2022-04-13 2025-01-07 엑스옥세미스 인코퍼레이티드 고형 암을 치료하기 위한 조성물 및 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004979A (en) * 1968-03-29 1977-01-25 Agence Nationale De Valorisation De La Recherche (Anvar) Preparation of active proteins cross-linked to inactive proteins
US4178362A (en) * 1969-06-03 1979-12-11 Telec S.A. Enzymatic dentifrices
US3638558A (en) * 1970-03-26 1972-02-01 Burger King Corp Cooking apparatus for comestibles immersed in heated oil
JPS528795B2 (en:Method) * 1971-12-30 1977-03-11
DE2214442C3 (de) * 1972-03-24 1981-09-10 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Überführung von Glucose in Gluconsäure
DE2307904A1 (de) * 1973-02-17 1974-08-29 Hoechst Ag Verwendung von katalasefreien oder katalsearmen glucoseoxidase-praeparaten als zytostatikum fuer maligne zellen
DK146942C (da) * 1978-04-19 1984-07-30 Novo Industri As Fremgangsmaade til fremstilling af et immobiliseret enzymprodukt
DE2911192A1 (de) * 1979-03-22 1980-10-02 Boehringer Sohn Ingelheim Neuartiges immobilisiertes glucoseoxidase-katalasepraeparat und seine verwendung zur enzymatischen glucoseoxidation

Also Published As

Publication number Publication date
ZA821924B (en) 1983-04-27
EP0062434B1 (en) 1985-09-25
NO158004B (no) 1988-03-21
CA1187791A (en) 1985-05-28
AR229260A1 (es) 1983-07-15
AU556620B2 (en) 1986-11-13
NO821167L (no) 1982-10-08
DK155082A (da) 1982-10-08
NO158004C (no) 1988-06-29
DE3266476D1 (en) 1985-10-31
IN156471B (en:Method) 1985-08-10
AU8173982A (en) 1982-10-14
IL65382A0 (en) 1982-05-31
US4486408A (en) 1984-12-04
JPS57177694A (en) 1982-11-01
IL65382A (en) 1986-04-29
EP0062434A1 (en) 1982-10-13

Similar Documents

Publication Publication Date Title
NL192637B (nl) Stelselprocessor.
DE3581630D1 (de) Verarbeitungssystem fuer wettspiel.
NL192228B (nl) Interruptsysteem.
IT8221288A0 (it) Mietitrebbia.
DE3684293D1 (de) Vielfachprozessorsystem.
NO154777C (no) Radarsystem.
NO159619C (no) Immunokjemisk enzymbestemmelse.
DE3483268D1 (de) Lastempfindliches system.
ATE15813T1 (de) Unloesliches vernetztes zytotoxisches oxidaseperoxidase-system.
ES264837Y (es) Conjunto reten.
ATE20218T1 (de) Lenksystem.
NO852772L (no) Vektorbehandlingssystem.
DE3587629D1 (de) Automatische Melkanlage.
ATE20219T1 (de) Lenksystem.
NL192755B (nl) Geheugenstelsel.
FI841212L (fi) Lastningssystem.
NO157755C (no) Navigasjonssystem.
NO822655L (no) Skruesystem.
NO822878L (no) Joggesko.
FI854853L (fi) Biltelefonsystem.
NO823502L (no) Hurtigavisingssystem.
FI823748A7 (fi) Kuivaussysteemi.
NO822783L (no) Ammunisjons-haandteringssystem.
FI843846L (fi) System foer luftfuktning.
ATE25149T1 (de) Selbsttaetiges immunotestsystem.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee